日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Single-cell proteo-transcriptomic profiling reveals altered characteristics of stem and progenitor cells in patients receiving cytoreductive hydroxyurea in early-phase chronic myeloid leukemia

单细胞蛋白质组学分析揭示了接受细胞减灭性羟基脲治疗的早期慢性粒细胞白血病患者干细胞和祖细胞特征的改变

Komic, Hana; Nilsson, Malin S; Wennström, Lovisa; Bandaru, Tagore Sanketh; Jaako, Pekka; Hellstrand, Kristoffer; Thorén, Fredrik B; Martner, Anna

Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines

利用霍乱毒素A1佐剂肽疫苗靶向小鼠转移性癌症

Paul, Sanchari; Kaya, Mustafa; Johnsson, Olivia; Grauers Wiktorin, Hanna; Törnell, Andreas; Arabpour, Mohammad; Hellstrand, Kristoffer; Martner, Anna

Histamine dihydrochloride and low-dose interleukin-2 in an emerging landscape of relapse prevention in acute myeloid leukemia

组胺二盐酸盐和低剂量白细胞介素-2在急性髓系白血病复发预防领域的新兴应用

Nilsson, Malin S; Martner, Anna; Wennström, Lovisa; Hansson, Markus; Thorén, Fredrik B; Hellstrand, Kristoffer

Impaired T-cell response to mRNA vaccination heralds risk of COVID-19 in long-term allogeneic hematopoietic stem cell transplantation survivors

长期接受异基因造血干细胞移植的患者对mRNA疫苗的T细胞反应受损,预示着感染COVID-19的风险增加

Einarsdottir, Sigrun; Waldenström, Jesper; Törnell, Andreas; Ringlander, Johan; Stenbäck, Joakim B; Malmström, Sebastian; Hellstrand, Kristoffer; Martner, Anna; Lagging, Martin

Histamine dihydrochloride and low-dose interleukin-2 has anti-leukemic efficacy in <i>NPM1</i>-mutated and myelomonocytic/monocytic acute myeloid leukemia

组胺二盐酸盐和低剂量白细胞介素-2对NPM1突变型和髓单核细胞/单核细胞型急性髓系白血病具有抗白血病疗效。

Nilsson, Malin S; Fiegl, Michael; Hiddemann, Wolfgang; Sperr, Wolfgang R; Thorén, Fredrik B; Martner, Anna; Hellstrand, Kristoffer

Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation

Comirnaty Omicron XBB.1.5 加强型 COVID-19 mRNA 疫苗在异基因造血干细胞移植长期生存者中的免疫原性

Einarsdottir, Sigrun; Al-Dury, Samer; Fridriksson, Ellen; Andius, Linn Dahlsten; Wang, Hao; Sharba, Sinan; Mountagui, Amin; Waern, Johan; Ringlander, Johan; Martner, Anna; Hellstrand, Kristoffer; Waldenström, Jesper; Lagging, Martin

Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation

异基因造血干细胞移植受者接种第三剂新冠疫苗的免疫原性降低

Einarsdottir, Sigrun; Martner, Anna; Nicklasson, Malin; Wiktorin, Hanna Grauers; Arabpour, Mohammad; Törnell, Andreas; Vaht, Krista; Waldenström, Jesper; Ringlander, Johan; Bergström, Tomas; Brune, Mats; Hellstrand, Kristoffer; Ljungman, Per; Lagging, Martin

Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia

更正:NK细胞激活受体基因变异对急性髓系白血病中受体表达和免疫治疗结果的影响

Hussein, Brwa Ali; Hallner, Alexander; Wennström, Lovisa; Brune, Mats; Martner, Anna; Hellstrand, Kristoffer; Bernson, Elin; Thorén, Fredrik B

Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia

急性髓系白血病复发预防性免疫疗法的临床疗效取决于诱导化疗第一个疗程后的完全缓解情况。

Nilsson, Malin S; Hallner, Alexander; Brune, Mats; Nilsson, Staffan; Thorén, Fredrik B; Martner, Anna; Hellstrand, Kristoffer

Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype

HDC/IL-2免疫疗法可能对正常核型的急性髓系白血病具有临床疗效。

Nilsson, Malin S; Hallner, Alexander; Brune, Mats; Nilsson, Staffan; Thorén, Fredrik B; Martner, Anna; Hellstrand, Kristoffer